Heart Diseases – Talk Bio

Actionable Insights Powered by AI

Eli Lilly Pays $1B Upfront to Acquire Verve Therapeutics, Expanding Cardiovascular Gene Editing Portfolio

1 month ago talkbio0Tagged Acquisition, Cardiovascular Diseases, eli lilly, Gene Modification, Heart Diseases, PCSK9 protein, human, VERVE-102

Eli Lilly; Verve Therapeutics; gene editing; cardiovascular disease; acquisition; PCSK9; VERVE-102; biotech; heart disease

Heartbeat Chronicles: Inspiring Stories and Breakthroughs in Cardiovascular Health

5 months ago talkbio0Tagged cardiac research, Cardiovascular system, Heart Diseases, heart health, medical advancements

Heart disease, patient stories, medical advancements, cardiac research, heart health, cardiovascular breakthroughs

FDA Approves Attruby (Acoramidis) for ATTR-CM, Offering New Hope for Patients with Transthyretin Cardiac Amyloidosis

8 months ago talkbio0Tagged Acoramidis, Approved, ATTR-CM, Attruby, BridgeBio Pharma, Heart Diseases, Prealbumin, Senile cardiac amyloidosis, United States Food and Drug Administration

Attruby, Acoramidis, FDA Approval, ATTR-CM, Transthyretin Cardiac Amyloidosis, BridgeBio Pharma, Heart Disease Treatment